CompletedPhase 4

Long-Acting Reversible Contraception

United States916 participantsStarted 2011-12

Plain-language summary

In the proposed study, women aged 18-29 seeking oral or injectable contraception will be offered an opportunity to try LARC instead; the FDA-approved options include two types of intrauterine products and one type of subdermal contraceptive implant. Over a 24 month period, the experiences of LARC users will be compared to the experiences of those opting for their initial short-acting method.

Who can participate

Age range18 Years – 29 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 to 29 years of age; * sexually active; * seeking oral or injectable contraception; * working cell phone; * working email account; * willingness to be contacted by the clinic staff or study coordinators; and, * willingness to complete questionnaires. Exclusion Criteria: * currently pregnant; * previous use of a long-acting reversible contraceptive (LARC) method; and, * medical contraindications for oral contraceptives and injectables.

What they're measuring

Contraceptive Method Discontinuation

Timeframe: 24 months

Trial details

NCT IDNCT01299116

SponsorFHI 360

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-06

Results submitted2017-11-14

View on ClinicalTrials.gov More Contraception trials